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Purpose: Epilepsy is the commonest serious neurological condition to affect adolescents. We established a nurse-led clinic for
young people with suspected or diagnosed epilepsy. Outcomes in all patients referred during the first 4 years after its inception
are reported.
Methods: A total of 301 adolescents were seen at the clinic during 1996–1999. Epilepsy was excluded in 135 (45%), including 5
receiving antiepileptic drug (AED) therapy. A single seizure occurred in 22 (7%) others. Seventy-six patients (25%) had treated
epilepsy and 68 (23%) were newly diagnosed.
Results: More than 1 year’s seizure freedom was achieved by 53% of patients, 76% with one AED, 16% with two and 3%
with three. Four (5%) patients remained seizure free off medication. Sixteen (11%) were lost to follow-up. Outcome was better
(P < 0.05) for newly diagnosed (59% seizure free) than for treated (47% seizure free) epilepsy and for idiopathic generalised
(60% seizure free) than for partial (46% seizure free) seizures (P < 0.02). Magnetic resonance imaging of brain was obtained
in 63 (85%) patients with localisation-related epilepsy. Findings were abnormal in 43%, including nine with cortical dysplasia,
eight with mesial temporal sclerosis and two with gliomas.
Conclusions: Epilepsy can be difficult to diagnose in adolescents. Outcomes were surprisingly poor suggesting the need for
improved services for this patient population.
© 2003 BEA Trading Ltd. Published by Elsevier Science Ltd. All rights reserved.
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INTRODUCTION
Epilepsy is the commonest serious neurological
condition to affect adolescents1, occurring in more
than 60 in 100 000 young people2. Adolescents with
epilepsy represent a uniquely vulnerable group3, 4.
The teenage years can be a time of physical and emo-
tional turmoil, complicated by peer group pressure,
educational decision-making, exposure to alcohol and
recreational drugs, relationship developments and
sexual realisation5, 6. Independence can be threatened
by restrictions on driving, employment choices and
recreational activities. Parents, relatives and friends
may have difficulty accepting the diagnosis, com-
pounding the stigma. Compliance with medication
can be a problem7. Inadequate seizure control is often
associated with poor quality of life8, 9. Even if seizure
freedom is attained, epilepsy has been shown to have
a deleterious effect on subsequent employment and
marriage prospects10.
An audit of adolescents referred to the epilepsy
service at the Western Infirmary in Glasgow was un-
dertaken in 199411. Increasing numbers of referrals
and lack of a specific management programme were
highlighted. This led to the establishment in 1996 of
one of the first nurse-led clinics for adolescents with
epilepsy in the United Kingdom. A prospective out-
come study was envisaged at its inception. Data from
all patients reviewed during 1996–1999 are presented.
METHODS
Between 1 January 1996 and 31 December 1999,
all patients referred to the adolescent clinic at the
Western Infirmary in Glasgow were recruited into
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the programme. The service was led by an epilepsy
nurse specialist. Criteria for referral were a definite
or possible first seizure or a known or possible di-
agnosis of epilepsy. The nurse specialist saw each
patient and accompanying family members within
2 weeks of referral and every 6–8 weeks thereafter
if appropriate. Urgent referrals were telephoned or
faxed to a dedicated ‘hotline’ and appointed the same
week.
At the first visit, the nurse specialist asked patients
and their relatives/carers to describe the events leading
to referral. This information was recorded in a struc-
tured protocol, together with demographic details, risk
factors (history of birth trauma, febrile convulsions,
family history), past medical and drug history12. Each
case was shared with medical staff who performed
physical and neurological examinations and made a
diagnosis on the basis of history and examination. All
data were entered into a computerised database and
a customised case-sheet containing copies of corre-
spondence and investigations was developed for each
individual. If the diagnosis was unclear, the patient
was reviewed until a decision was made whether
or not he or she had epilepsy. To aid classification
of seizure type and epilepsy syndrome, routine and
sleep-deprived electroencephalography were under-
taken as necessary. Brain neuroimaging was requested
in patients with possible localisation-related epilepsy.
Seizure and syndrome classification was carried out
in accordance with the guidelines of the International
League Against Epilepsy13.
Patients who did not have epilepsy were discharged
to the care of their general practitioner. Adolescents
with seizures or suspected epilepsy were provided
with description and frequency charts. Following a
single seizure, the nurse specialist counselled pa-
tients about implications on driving, education, em-
ployment, sport, stress, sleep deprivation and other
lifestyle factors. Those shown to be photosensitive
were given advice on avoidance procedures. Each in-
dividual was provided with a telephone contact card,
facilitating support between clinic appointments and
enabling rapid review if further seizures occurred. To
ensure that family, friends and teachers were comfort-
able with the diagnosis and its implications, home and
school visits were undertaken by the nurse specialist
as necessary. Patients who missed a clinic visit were
sent two further appointments by post. Those who
did not keep all three appointments were classified as
defaulters.
The initiation of antiepileptic drug (AED) treat-
ment was considered for any patient who had had
two or more seizures, at least one of which required
a witness. AEDs were prescribed by medical staff
after consultation with the nurse specialist. Choice of
drug depended on the seizure type or epilepsy syn-
drome and the spectrum, side effects and interaction
profile of the AEDs14. Prior to starting treatment, the
implications and prophylactic nature of drug therapy
and the common side effects were discussed with
the patient and family. Girls were advised, as neces-
sary, about potential teratogenesis and the effects of
hepatic enzyme-inducing AEDs on the metabolism
of oestrogen- and progesterone-containing contracep-
tives. The use of high dose folic acid pre-conceptually
and in the first trimester of pregnancy was also dis-
cussed. Patients were given written information on
these topics, as well as leaflets on support organi-
sations for people with epilepsy. Adherence to drug
regimens was emphasised and compliance was mon-
itored by measurement of AED plasma levels during
the clinic visit15. Doses were titrated according to
efficacy and tolerability until seizure freedom or
optimal control was obtained. When the first AED
was not well tolerated or failed to control seizures,
a second was substituted. If a poor result was again
obtained, duotherapy was tried16.
Patients were reviewed at the clinic until seizure
freedom was achieved. Seizure freedom was defined
as the absence of seizures or auras for at least the
previous year on unchanged doses of AEDs or off
medication17. Seizure-free patients were invited to
contact the Epilepsy Unit via a dedicated telephone
line should a further seizure occur. Patients with re-
current seizures continued to attend the clinic. The
Chi-square test was employed for comparison of
categorical data. All statistical tests were two-tailed.
RESULTS
A total of 301 patients (aged 10–18 years; mean 16
years) were referred to the service during the first 4
years after its inception. General practitioners referred
231 (77%), with 37 (12%) coming from the accident
and emergency department18 and 33 (11%) from other
hospital clinics. A diagnosis of epilepsy was made in
144 (48%) patients. Twenty-two (7%) others had a
single seizure, 10 of which were provoked (8 reflex
anoxic, 1 drug-related, 1 alcohol withdrawal). The re-
maining 135 (45%) patients were not thought to have
had seizures, including 5 patients who were taking
AED therapy on referral (Table 1).
In the 144 patients with epilepsy, age of onset
ranged from <1–17 years (mean 11 years). Seventy-
six (53%) had treated epilepsy (Table 2). Forty-four
(58%) patients described partial seizures with or
without secondary generalisation, with the remaining
32 (42%) having idiopathic generalised epilepsy (14
tonic–clonic, 11 myoclonic, 7 absence). Sixty-eight
(47%) patients had newly diagnosed untreated epil-
epsy, 30 (44%) of whom were categorised as having
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Table 1: Categorisation of patients referred to the
adolescent clinic.
Diagnosis Number (%)
Epilepsy 144 (48)
Single unprovoked seizure 12 (4)
Single provoked seizure 10 (3)
Vasovagal episodes 65 (22)
Panic attacks 6 (2)
Non-epileptic seizures 3 (1)
Uncertain 61 (20)
Total 301 (100)
Table 2: Characteristics of teenagers with newly diagnosed
and refractory epilepsy.
Newly Already
diagnosed treated
Number (%) 68 (47) 76 (53)
Female/male 33:35 44:32
Age in years (mean) 10–18 (15) 12–18 (15)
Seizure type (%)
Partial/secondary generalised 30 (44) 44 (58)
Primary generalised 38 (56) 32 (42)
Classification (%)
Idiopathic 38 (56) 32 (42)
Cryptogenic 16 (23) 20 (26)
Symptomatic 9 (13) 18 (24)
Unclassifiable 5 (8) 6 (8)
Risk factors
Family history (%) 24 (35) 25 (33)
Birth trauma (%) 12 (18) 11 (14)
Febrile convulsions (%) 9 (13) 14 (18)
partial seizures with or without secondary generali-
sation and 38 (56%) idiopathic generalised epilepsy
(29 tonic–clonic, 7 myoclonic, 2 absence). Seventeen
patients had learning disabilities19. Risk factors were
identified in 70 patients (Table 3), none of which
had prognostic value in predicting subsequent seizure
control.
Following manipulation of AED treatment, 76
(53%) adolescents became seizure free for at least the
Fig. 1: Outcomes in adolescents with newly diagnosed and treated epilepsy. ∗P <0.05 newly diagnosed versus treated at referral.
Table 3: Risk factors for seizures and epilepsy.
Febrile Family Birth
convulsions history trauma
(%) (%)a (%)
Localisation-related 17 (23) 24 (32) 11 (15)
Idiopathic generalised 6 (9) 25 (36) 12 (17)
Totalb 23 (16) 49 (34) 23 (16)
a Family history in a first degree relative; b Some patients had
more than one risk factor.
previous year (Fig. 1). Fifty-two (36%) patients con-
tinued to have seizures. Sixteen (11%) were lost to
follow-up. Adolescents were significantly less likely
to become controlled if they had treated epilepsy
(47% seizure free) as opposed to being newly diag-
nosed (59% seizure free) at referral (P < 0.05). This
was particularly the case for those with partial-onset
seizures (P < 0.01). Significantly, more patients
with idiopathic generalised seizures (60% controlled)
became seizure free than those with partial (46%
controlled) seizures (P < 0.02). Patients with con-
comitant learning disabilities were less likely to have
their seizures controlled (P < 0.01) compared to the
remainder of the cohort, with seizure freedom being
attained in just four (23%). The majority (76%) of
seizure-free patients were taking a single AED with
the remainder receiving two (16%) or three (3%)
drugs (Table 4). Four (5%) patients remained seizure
free off AED medication.
Magnetic resonance imaging (MRI) of brain
was obtained in 63 (85%) of the patients with
localisation-related epilepsy (Table 5). This was re-
ported as normal in 36 (57%) patients, who were clas-
sified as having cryptogenic epilepsy. Of the 27 (43%)
with abnormal brain MRI findings, 9 (14%) had corti-
cal dysplasia (CD), 8 (13%) mesial temporal sclerosis
(MTS), 5 (8%) cortical gliosis, 3 (5%) hydrocephalus
and 2 (3%) gliomas. These latter two were referred to
a neurosurgical centre for surgical excision. Adoles-
cents with underlying MTS and cryptogenic epilepsy
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Table 4: Antiepileptic drug therapy in seizure-free patients.
Drug treatment Idiopathic generalised seizures Partial ± secondary generalised seizures Total
Lamotrigine 14 6 20
Sodium valproate 16 3 19
Carbamazepine 4 10 14
Others 4 1 5
Sodium valproate + lamotrigine 3 1 4
Lamotrigine + gabapentin 0 2 2
Phenytoin + gabapentin 0 2 2
Sodium valproate + topiramate 0 1 1
Carbamazepine + phenytoin 0 1 1
Carbamazepine + topiramate 0 1 1
Carbamazepine + vigabatrin 0 1 1
Three antiepileptic drugs 1 1 2
None 0 4 4
Total 42 34 76
Table 5: Brain magnetic resonance imaging in newly diagnosed and treated adolescents with localisation-related epilepsy.
Findings Newly diagnosed Already treated
Patients (%) Seizure free (%) Patients (%) Seizure free (%)
Normal 16 (64) 8 (50) 20 (52) 6 (30)
CD 3 (12) 3 (100) 6 (16) 3 (50)
MTS 3 (12) 1 (33) 5 (13) 0 (0)
Gliosis 1 (4) 1 (100) 4 (11) 2 (50)
Hydrocephalus 1 (4) 1 (100) 2 (5) 1 (50)
Neoplasm 1 (4) 1 (100) 1 (3) 1 (100)
Total 25 (100) 15 (60) 38 (100) 13 (34)
CD = cortical dysplasia, MTS = mesial temporal sclerosis.
Fig. 2: Seizure-free rates in relation to underlying structural abnormalities. MTS = mesial temporal sclerosis, CD = cortical
dysplasia. ∗P < 0.001 compared to other treatment groups.
were likely to have a poorer outcome with only 13
and 39%, respectively, becoming seizure free (Fig. 2).
DISCUSSION
The format for this clinic was developed after an audit
highlighted deficiencies in our service for adole-
scents11. As young people with epilepsy were percei-
ved to be a vulnerable group, a nurse-led service was
felt appropriate for this population. Patients who were
cared for by nurse specialists reported a higher qual-
ity of service, reduced waiting times, and improved
continuity of care20, 21. Benefits were gained from
ready accessibility to support and the identification
of compliance problems and AED side effects22, 23.
The majority of patients were referred from gen-
eral practice with a smattering from the accident and
emergency department and secondary care. Despite
the fact that the adolescent service was promoted as a
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specialist clinic, only 48% of patients were given a
diagnosis of epilepsy with a further 7% having had a
single seizure. Epilepsy is recognised as being difficult
to diagnose24, with over one quarter of patients being
wrongly considered to have ‘refractory epilepsy’25, 26.
AEDs were withdrawn in five adolescents in the cur-
rent cohort who did not have epilepsy. Only 11% were
lost to follow-up. Although youth is recognised to be
associated with non-attendance at out-patient clinics,
this is similar to the national figure of 12% for all age
groups27. Our dedicated nurse-led service with open
telephone contact may have reduced the number of
patients who defaulted from appointments.
Significant pathology was found in 36% of the
74 patients with localisation-related epilepsy, includ-
ing 9 with CD, 8 with MTS and 2 with gliomas.
Over half of the patients who became seizure free
had abnormal MRI results. There was no statistical
difference between the number of seizure-free and
uncontrolled adolescents with identified pathology.
MTS was associated with the poorest outcome, as
has been reported in other series28–30. However, only
39% of patients with localisation-related epilepsy,
who had normal brain MRI, became seizure free.
Some of these patients will have cortical microdys-
plasia which can be identified with more sophisticated
neuroimaging techniques31. These findings have im-
portant prognostic implications for young people with
epilepsy.
The relationship between febrile convulsions and
the development of afebrile seizures later in life is
well recognised, although population-based studies
suggest that this link is weaker than do hospital-based
reports32. In this study, a greater percentage of pa-
tients with partial-onset seizures had a history of
febrile convulsions than those with idiopathic gener-
alised epilepsies. Annegers et al.33 reported similar
findings. We found no significant association between
febrile convulsions and subsequent seizure control as
has been reported in other patient populations17, 34.
Prognosis was significantly poorer in patients al-
ready taking medication at referral, particularly those
with partial seizures. This likely reflects the fact that
some of these patients were referred because of prob-
lematic or refractory epilepsy. An inadequate response
to initial AED treatment is a powerful predictor of
refractory epilepsy in adults and children17, 35. As in
other studies, poor seizure control was more likely in
patients with learning disabilities36, 37. Most patients
who were seizure free received AED monotherapy.
However, 19% were controlled with more than one
drug, supporting the observation that combining two,
or at the most, three AEDs can be a useful therapeutic
option when monotherapy fails38.
Despite attending a dedicated clinic, only 53% of
adolescents became seizure free with AED treatment.
The highest figure would have been 64% if all default-
ing patients were well controlled. This poor outcome
may reflect unidentified problems with compliance.
Using therapeutic drug monitoring, we were able
to counsel some patients who were not adhering to
their drug regimen. Poor compliance with medication
is a huge problem in young people. Approximately
50% of teenagers with chronic conditions have dif-
ficulty in complying with treatment23. Contrary to
what might be expected, this does not correlate with
clinic non-attendance39. Good compliance occurred
in well-motivated patients with a positive attitude to-
wards epilepsy who had good support from family,
nurses and doctors7.
CONCLUSIONS
Epilepsy can be a difficult diagnosis to make in ado-
lescents. Almost half of the patients referred to the
service had a different problem. Brain MRI detected
significant pathology in seizure-free and refractory
patients with localisation-related epilepsy, yielding
important prognostic information. Results suggest
that outcome may be poorer than expected in this age
group. These factors highlight the need for accurate
diagnosis, prompt investigation, and appropriate treat-
ment for young people with epilepsy. This analysis
has prompted the setting up of a randomised prospec-
tive study comparing the impact of our specialist ser-
vice with standard out-patient care on seizure control
and psychological and social outcomes in adolescents
with newly diagnosed epilepsy.
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